Skip to main navigation

About Us
Our Science
Leadership Team
Contact
Investors & Press

Press Releases

Overview
Press Releases
Events & Presentations
SEC Filings & Tax Forms
Stock Information
Analyst Coverage
Corporate Governance
Email Alerts

Investor Contacts

ir@kalaristx.com

Media Contacts

media@kalaristx.com

Year

May 12, 2026

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates

Mar 17, 2026

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

Jan 28, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

© Kalaris Therapeutics 2026. All rights reserved.